Pharmacologic management of metabolic and alcohol-associated liver disease.

Pagadala M, Jalil S, Dunn N, Singal AK

DOI: 10.20517/mtod.2026.29
Published: 2026 Jun
Container: Metabolism and target organ damage
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.20517/mtod.2026.29,
  title = {Pharmacologic management of metabolic and alcohol-associated liver disease.},
  author = {Pagadala M and Jalil S and Dunn N and Singal AK},
  year = {2026},
  journal = {Metabolism and target organ damage},
  doi = {10.20517/mtod.2026.29},
  url = {https://doi.org/10.20517/mtod.2026.29}
}

RIS

TY  - JOUR
TI  - Pharmacologic management of metabolic and alcohol-associated liver disease.
AU  - Pagadala M
AU  - Jalil S
AU  - Dunn N
AU  - Singal AK
PY  - 2026
JO  - Metabolism and target organ damage
DO  - 10.20517/mtod.2026.29
UR  - https://doi.org/10.20517/mtod.2026.29
ER  -

APA

M, P., S, J., N, D., & AK, S. (2026). Pharmacologic management of metabolic and alcohol-associated liver disease.. Metabolism and target organ damage. https://doi.org/10.20517/mtod.2026.29

Source records

pubmed · retrieved 2026-09-27T09:48:01.871Z